Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Statistics

Total Valuation

NRIX has a market cap or net worth of $874.42 million. The enterprise value is $351.37 million.

Market Cap	874.42M
Enterprise Value	351.37M

Important Dates

The last earnings date was Tuesday, April 8, 2025, after market close.

Earnings Date	Apr 8, 2025
Ex-Dividend Date	n/a

Share Statistics

NRIX has 76.24 million shares outstanding. The number of shares has increased by 36.16% in one year.

Current Share Class	76.24M
Shares Outstanding	76.24M
Shares Change (YoY)	+36.16%
Shares Change (QoQ)	+6.57%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	85.90%
Float	59.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.10
Forward PS	14.47
PB Ratio	1.82
P/TBV Ratio	1.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.26, with a Debt / Equity ratio of 0.06.

Current Ratio	6.26
Quick Ratio	6.13
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.16% and return on invested capital (ROIC) is -40.87%.

Return on Equity (ROE)	-64.16%
Return on Assets (ROA)	-31.08%
Return on Invested Capital (ROIC)	-40.87%
Return on Capital Employed (ROCE)	-43.93%
Revenue Per Employee	$197,262
Profits Per Employee	-$728,678
Employee Count	286
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

In the past 12 months, NRIX has paid $180,000 in taxes.

Income Tax	180,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.20% in the last 52 weeks. The beta is 2.24, so NRIX's price volatility has been higher than the market average.

Beta (5Y)	2.24
52-Week Price Change	-7.20%
50-Day Moving Average	12.92
200-Day Moving Average	19.88
Relative Strength Index (RSI)	50.33
Average Volume (20 Days)	1,310,634

Short Selling Information

The latest short interest is 14.39 million, so 18.87% of the outstanding shares have been sold short.

Short Interest	14.39M
Short Previous Month	12.16M
Short % of Shares Out	18.87%
Short % of Float	24.34%
Short Ratio (days to cover)	12.00

Income Statement

In the last 12 months, NRIX had revenue of $56.42 million and -$208.40 million in losses. Loss per share was -$2.81.

Revenue	56.42M
Gross Profit	-184.87M
Operating Income	-230.67M
Pretax Income	-164.82M
Net Income	-208.40M
EBITDA	-222.35M
EBIT	-230.67M
Loss Per Share	-$2.81

Balance Sheet

The company has $549.68 million in cash and $26.62 million in debt, giving a net cash position of $523.06 million or $6.86 per share.

Cash & Cash Equivalents	549.68M
Total Debt	26.62M
Net Cash	523.06M
Net Cash Per Share	$6.86
Equity (Book Value)	480.92M
Book Value Per Share	6.31
Working Capital	473.72M

Cash Flow

In the last 12 months, operating cash flow was -$191.72 million and capital expenditures -$9.87 million, giving a free cash flow of -$201.59 million.

Operating Cash Flow	-191.72M
Capital Expenditures	-9.87M
Free Cash Flow	-201.59M
FCF Per Share	-$2.64

Margins

Gross Margin	n/a
Operating Margin	-408.87%
Pretax Margin	-369.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRIX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.16%
Shareholder Yield	-36.16%
Earnings Yield	-23.83%
FCF Yield	-23.05%

Analyst Forecast

The average price target for NRIX is $30.71, which is 167.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.71
Price Target Difference	167.74%
Analyst Consensus	Strong Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	51.65%
EPS Growth Forecast (5Y)	-30.45%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NRIX has an Altman Z-Score of 3.71 and a Piotroski F-Score of 2.

Altman Z-Score	3.71
Piotroski F-Score	2